In vitro and in planta study reveals widespread pyraclostrobin resistance in Botrytis cinerea, suggesting non-QoI fungicide rotation preserves sensitivity.
Botrytis cinerea, the causal agent of gray mold, is a major pathogen in strawberry production. Quinone outside inhibitor (QoI) fungicides have been widely used for disease control, but resistance driven by the G143A mutation in cytochrome b (cytb) has limited their field efficacy. This study evaluated the sensitivity of 229 B. cinerea isolates collected from farms in major Korean strawberry-growing regions during 2022-2024 to the QoI fungicide pyraclostrobin. The EC50 values for pyraclostrobin ranged from 0.10 to 329.21 μg mL-1. In total, 86.46% of the population showed resistance to pyraclostrobin, harboring the G143A mutation in cytb. In planta and greenhouse assays confirmed that pyraclostrobin failed to control the QoI-resistant isolates. Furthermore, strong cross-resistance to pyraclostrobin, mandestrobin, and pyribencarb indicates that QoI-resistant populations substantially limit the field efficacy of QoI fungicides. To assess how the QoI resistance mutation affects selection under non-QoI fungicide pressure, mixed QoI-sensitive and -resistant isolates were treated with alternative fungicides. Allele-specific qPCR revealed that pydiflumetofen, fludioxonil, and fluxapyroxad maintained a higher proportion of the QoI-sensitive genotype at all concentrations, whereas pyraclostrobin consistently favored the resistant genotype. These findings indicated that QoI fungicides impose strong selection pressure promoting resistant B. cinerea populations, while non-QoI fungicides help maintain sensitive individuals. Our study suggests the need for fungicide class rotation and the targeted use of non-QoI fungicides to delay QoI resistance development and preserve the efficacy of gray mold management in strawberry production.
No takes yet. Share an insight, caveat, or question.
Jang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: